1. Cauvin, C., Loutzenhizer, R., van Breemen, C., 1983, Mechanisms of calcium antagonist-induced vasodilation, Ann. Rev Pharmacol Toxicol., 23: 373.
2. Cox, R. H. and Kikta, D. C., 1989, Comparison of norepinephrine (NE) activated 86Rb efflux in arteries from genetically obese Zucker rats, FASEB J., 3: A1009.
3. Dornfeld, L. P., Maxwell, M. H., Waks, A., and Tuck, M., 1987, Mechanisms of hypertension in obesity, Kidney Internat’l., 32: S254.
4. Jones, A. W. and Smith, J. S., 1986, Altered Ca-dependent fluxes of 42K in rat aorta during aldosterone-salt hypertension, in: “Recent Advances in Arterial Diseases: Atherosclerosis, Hypertension, and Vasospasm”, T. N. Tulenko and R. H. Cox, eds., Alan R. Liss, New York, p. 265.
5. Kurtz, T. Z., Morris, R. C., and Pershadsingh, H. A., 1989, The Zucker fatty rat as a genetic model of obesity and hypertension, Hypertension, 13: 896.